Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endorphins, dopamine, and schizophrenia.

J Volavka, L G Davis, Y H Ehrlich

    Schizophrenia Bulletin
    |January 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    This study proposes a unified model for schizophrenia, suggesting that endorphin system alterations may cause the dopaminergic hyperactivity implicated in the disease. Further research is needed to confirm this link.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Response to Comment on "Late Upper Paleolithic occupation at Cooper's Ferry, Idaho, USA, ~16,000 years ago".

    Science (New York, N.Y.)·2020
    Same author

    Reply by Authors.

    The Journal of urology·2019
    Same author

    Hostility in schizophrenia: An integrated analysis of the combined Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and the European First Episode Schizophrenia Trial (EUFEST) studies.

    European psychiatry : the journal of the Association of European Psychiatrists·2015
    Same author

    Development of new antiatherosclerotic and antithrombotic drugs utilizing F11 receptor (F11R/JAM-A) peptides.

    Biopolymers·2014
    Same author

    Distribution of endogenously phosphorylated proteins in subcellular fractions of rat cerebral cortex.

    Neurochemical research·2013
    Same author

    ITAREPS relapse prevention in schizophrenia.

    International journal of clinical practice·2009
    Same journal

    The Effect of Semaglutide on Antipsychotic-Induced Weight Gain and Other Metabolic Parameters, among a Cohort of Inpatients.

    Schizophrenia bulletin·2026
    Same journal

    Comparing Apples to Oranges Obscures Tortoises Beating Hares: The Relationship Between Rate of Antipsychotic Tapering and Relapse.

    Schizophrenia bulletin·2026
    Same journal

    Beyond the Need for Speed: D2 Receptor Affinity Predicts Relapse after Antipsychotic Tapering in First Episode Psychosis.

    Schizophrenia bulletin·2026
    Same journal

    Correction to: The Mini-CAARMS: Development and Validation of a Short Version of the Comprehensive Assessment of AT Risk Mental States to Facilitate Preventive Psychiatry.

    Schizophrenia bulletin·2026
    Same journal

    Longitudinal Impact of Birthweight and its Polygenic Risk Score on Glucose and Antipsychotic-Induced Weight Gain in First Episode Psychosis.

    Schizophrenia bulletin·2026
    Same journal

    The Key to Clozapine Mystery May Lie in its Shape.

    Schizophrenia bulletin·2026
    See all related articles

    Area of Science:

    • Neuroscience
    • Psychiatry
    • Molecular Biology

    Background:

    • Schizophrenia pathogenesis is linked to dopaminergic synaptic transmission alterations.
    • Emerging theories connect the endorphin system to schizophrenia etiology.
    • A functional relationship between endorphin and dopamine systems is increasingly recognized.

    Purpose of the Study:

    • To propose a unified model integrating the dopaminergic and endorphin systems in schizophrenia.
    • To explore how endorphins modulate dopaminergic transmission.
    • To hypothesize that endorphin system alterations may underlie dopaminergic hyperactivity in schizophrenia.

    Main Methods:

    • Review of neurochemical and pharmacological findings.
    • Analysis of molecular mechanisms of endorphin-dopamine interaction (e.g., nucleotide cyclases, protein phosphorylation).

    Related Experiment Videos

  • Examination of therapeutic experiments testing hypotheses in schizophrenic patients.

    • Main Results:

    • Endorphins exert presynaptic and postsynaptic effects on dopaminergic transmission.
    • Modulation involves molecular pathways including nucleotide cyclases and protein phosphorylation.
    • Therapeutic experiments have not yet provided definitive results.

    Conclusions:

    • A combined model integrating endorphin and dopamine systems offers a new perspective on schizophrenia.
    • Primary alterations in the endorphin system could be the cause of dopaminergic hyperactivity in schizophrenia.
    • Further investigation is required to validate these hypotheses and their therapeutic implications.